Chih‐Hsi S. Kuo

T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED

Chih‐Hsi S. Kuo, Stelios Pavlidis, Matthew J. Loza et al. · European Respiratory Journal · 2017 · 360 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Kōichi Goto, Yasushi Goto, Toshio Kubo et al. · Journal of Clinical Oncology · 2023 · 299 citations · Full text

Medicine, Oncology, Pharmacology +17

A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED

Chih‐Hsi S. Kuo, Stelios Pavlidis, Matthew J. Loza et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 211 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma

Christos Rossios, Stelios Pavlidis, Uruj Hoda et al. · Journal of Allergy and Clinical Immunology · 2017 · 205 citations

Life Sciences, Immunology, Molecular Medicine +16

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

D. Ross Camidge, Jair Bar, Hidehito Horinouchi et al. · Journal of Clinical Oncology · 2024 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17